tiprankstipranks
Trending News
More News >
Wells upgrades Bicara to Equal Weight with thesis played out
PremiumThe FlyWells upgrades Bicara to Equal Weight with thesis played out
21d ago
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
Premium
The Fly
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
21d ago
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
Premium
The Fly
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
21d ago
Bicara Therapeutics publishes updated data from Phase 1/1b trial of Ficerafusp
PremiumThe FlyBicara Therapeutics publishes updated data from Phase 1/1b trial of Ficerafusp
22d ago
Bicara Therapeutics Inc.: Promising Clinical Trials and Stable Financial Outlook Support Buy Rating
Premium
Ratings
Bicara Therapeutics Inc.: Promising Clinical Trials and Stable Financial Outlook Support Buy Rating
28d ago
Bicara Therapeutics price target lowered to $41 from $44 at H.C. Wainwright
Premium
The Fly
Bicara Therapeutics price target lowered to $41 from $44 at H.C. Wainwright
28d ago
Bicara Therapeutics reports Q1 EPS (68c), consensus (40c)
PremiumThe FlyBicara Therapeutics reports Q1 EPS (68c), consensus (40c)
1M ago
Promising Potential of Bicara Therapeutics’ Ficerafusp Alfa Drives Buy Rating Amid Encouraging Clinical Data and Growth Opportunities
Premium
Ratings
Promising Potential of Bicara Therapeutics’ Ficerafusp Alfa Drives Buy Rating Amid Encouraging Clinical Data and Growth Opportunities
1M ago
Cautious Outlook on Bicara Therapeutics Inc. Amid Efficacy and Safety Concerns for Ficerafusp
Premium
Ratings
Cautious Outlook on Bicara Therapeutics Inc. Amid Efficacy and Safety Concerns for Ficerafusp
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100